Cargando…
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
High-mobility group box 1 (HMGB1) is a nuclear factor that is released extracellularly as a late mediator of lethality in sepsis as well as after necrotic, but not apoptotic, death. Here we demonstrate that in contrast to the delayed role of HMGB1 in the systemic inflammation of sepsis, HMGB1 acts a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213120/ https://www.ncbi.nlm.nih.gov/pubmed/15795240 http://dx.doi.org/10.1084/jem.20042614 |
_version_ | 1782148829217292288 |
---|---|
author | Tsung, Allan Sahai, Rohit Tanaka, Hiroyuki Nakao, Atsunori Fink, Mitchell P. Lotze, Michael T. Yang, Huan Li, Jianhua Tracey, Kevin J. Geller, David A. Billiar, Timothy R. |
author_facet | Tsung, Allan Sahai, Rohit Tanaka, Hiroyuki Nakao, Atsunori Fink, Mitchell P. Lotze, Michael T. Yang, Huan Li, Jianhua Tracey, Kevin J. Geller, David A. Billiar, Timothy R. |
author_sort | Tsung, Allan |
collection | PubMed |
description | High-mobility group box 1 (HMGB1) is a nuclear factor that is released extracellularly as a late mediator of lethality in sepsis as well as after necrotic, but not apoptotic, death. Here we demonstrate that in contrast to the delayed role of HMGB1 in the systemic inflammation of sepsis, HMGB1 acts as an early mediator of inflammation and organ damage in hepatic ischemia reperfusion (I/R) injury. HMGB1 levels were increased during liver I/R as early as 1 h after reperfusion and then increased in a time-dependent manner up to 24 h. Inhibition of HMGB1 activity with neutralizing antibody significantly decreased liver damage after I/R, whereas administration of recombinant HMGB1 worsened I/R injury. Treatment with neutralizing antibody was associated with less phosphorylation of c-Jun NH(2)-terminal kinase and higher nuclear factor–κB DNA binding in the liver after I/R. Toll-like receptor 4 (TLR4)-defective (C3H/Hej) mice exhibited less damage in the hepatic I/R model than did wild-type (C3H/HeOuj) mice. Anti-HMGB1 antibody failed to provide protection in C3H/Hej mice, but successfully reduced damage in C3H/Ouj mice. Together, these results demonstrate that HMGB1 is an early mediator of injury and inflammation in liver I/R and implicates TLR4 as one of the receptors that is involved in the process. |
format | Text |
id | pubmed-2213120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22131202008-03-11 The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion Tsung, Allan Sahai, Rohit Tanaka, Hiroyuki Nakao, Atsunori Fink, Mitchell P. Lotze, Michael T. Yang, Huan Li, Jianhua Tracey, Kevin J. Geller, David A. Billiar, Timothy R. J Exp Med Article High-mobility group box 1 (HMGB1) is a nuclear factor that is released extracellularly as a late mediator of lethality in sepsis as well as after necrotic, but not apoptotic, death. Here we demonstrate that in contrast to the delayed role of HMGB1 in the systemic inflammation of sepsis, HMGB1 acts as an early mediator of inflammation and organ damage in hepatic ischemia reperfusion (I/R) injury. HMGB1 levels were increased during liver I/R as early as 1 h after reperfusion and then increased in a time-dependent manner up to 24 h. Inhibition of HMGB1 activity with neutralizing antibody significantly decreased liver damage after I/R, whereas administration of recombinant HMGB1 worsened I/R injury. Treatment with neutralizing antibody was associated with less phosphorylation of c-Jun NH(2)-terminal kinase and higher nuclear factor–κB DNA binding in the liver after I/R. Toll-like receptor 4 (TLR4)-defective (C3H/Hej) mice exhibited less damage in the hepatic I/R model than did wild-type (C3H/HeOuj) mice. Anti-HMGB1 antibody failed to provide protection in C3H/Hej mice, but successfully reduced damage in C3H/Ouj mice. Together, these results demonstrate that HMGB1 is an early mediator of injury and inflammation in liver I/R and implicates TLR4 as one of the receptors that is involved in the process. The Rockefeller University Press 2005-04-04 /pmc/articles/PMC2213120/ /pubmed/15795240 http://dx.doi.org/10.1084/jem.20042614 Text en Copyright © 2005, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Tsung, Allan Sahai, Rohit Tanaka, Hiroyuki Nakao, Atsunori Fink, Mitchell P. Lotze, Michael T. Yang, Huan Li, Jianhua Tracey, Kevin J. Geller, David A. Billiar, Timothy R. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion |
title | The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion |
title_full | The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion |
title_fullStr | The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion |
title_full_unstemmed | The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion |
title_short | The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion |
title_sort | nuclear factor hmgb1 mediates hepatic injury after murine liver ischemia-reperfusion |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213120/ https://www.ncbi.nlm.nih.gov/pubmed/15795240 http://dx.doi.org/10.1084/jem.20042614 |
work_keys_str_mv | AT tsungallan thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT sahairohit thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT tanakahiroyuki thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT nakaoatsunori thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT finkmitchellp thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT lotzemichaelt thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT yanghuan thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT lijianhua thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT traceykevinj thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT gellerdavida thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT billiartimothyr thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT tsungallan nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT sahairohit nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT tanakahiroyuki nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT nakaoatsunori nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT finkmitchellp nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT lotzemichaelt nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT yanghuan nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT lijianhua nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT traceykevinj nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT gellerdavida nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion AT billiartimothyr nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion |